GIORDANO, SILVIA
GIORDANO, SILVIA
SCIENZE MEDICHE
Anti‐IL17 Secukinumab in hidradenitis suppurativa: A long‐term drug survival analysis
2024-01-01 Roccuzzo, Gabriele; Repetto, Federica; Giordano, Silvia; Sarda, Cristina; Comes, Arianna; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome?
2022-01-01 Cavallo, Francesco; Roccuzzo, Gabriele; Avallone, Gianluca; Conforti, Claudio; Zalaudek, Iris; Giordano, Silvia; Rubatto, Marco; Fava, Paolo; Ribero, Simone; Quaglino, Pietro
Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks
2022-01-01 Mastorino, L; Cantafio Duò, V L; Vecco, C; Gelato, F; Giordano, S; Roccuzzo, G; Cavaliere, G; Avallone, G; Ortoncelli, M; Ribero, S; Quaglino, P
Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas
2022-01-01 Berrino, Enrico; Annaratone, Laura; Bellomo, Sara Erika; Ferrero, Giulio; Gagliardi, Amedeo; Bragoni, Alberto; Grassini, Dora; Guarrera, Simonetta; Parlato, Caterina; Casorzo, Laura; Panero, Mara; Sarotto, Ivana; Giordano, Silvia; Cereda, Matteo; Montemurro, Filippo; Ponzone, Riccardo; Crosetto, Nicola; Naccarati, Alessio; Sapino, Anna; Marchiò, Caterina
New and emerging therapies in cutaneous T-cell lymphoma
2024-01-01 Roccuzzo, Gabriele; Macagno, Nicole; Giordano, Silvia; Fava, Paolo; Quaglino, Pietro
Nonmelanoma skin cancer arising on tattoos
2022-01-01 Rubatto, Marco; Gelato, Federica; Mastorino, Luca; Giordano, Silvia; Ribero, Simone; Quaglino, Pietro
Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center
2023-01-01 Roccuzzo, Gabriele; Giordano, Silvia; Granato, Thomas; Cavallo, Francesco; Mastorino, Luca; Avallone, Gianluca; Pasini, Barbara; Quaglino, Pietro; Ribero, Simone
Pyoderma gangrenosum during infliximab in severe hidradenitis suppurativa: A paradoxical event
2024-01-01 Giordano, Silvia; Repetto, Federica; Boskovic, Sara; Roccuzzo, Gabriele; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone; Quaglino, Pietro
Pyogenic-granuloma-like skin metastasis as first sign of hepatocarcinoma
2024-01-01 GIORDANO, Silvia; ROCCUZZO, Gabriele; WITEL, Gianluca; CHIUSA, Luigi; CASSONI, Paola; RIBERO, Simone; QUAGLINO, Pietro
Rapidly evolving nasal ulceration: a clinical challenge
2023-01-01 ROCCUZZO, Gabriele; BARDINI, Daniela; GIORDANO, Silvia; CONTI, Luca; RIBERO, Simone; QUAGLINO, Pietro
Reply to ‘The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et al
2022-01-01 Avallone G.; Giordano S.; Astrua C.; Merli M.; Senetta R.; Conforti C.; Ribero S.; Marzano A.V.; Quaglino P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti‐IL17 Secukinumab in hidradenitis suppurativa: A long‐term drug survival analysis | 2024 | Roccuzzo, Gabriele; Repetto, Federica; Giordano, Silvia; Sarda, Cristina; Comes, Arianna; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone | |
| Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? | 2022 | Cavallo, Francesco; Roccuzzo, Gabriele; Avallone, Gianluca; Conforti, Claudio; Zalaudek, Iris; Giordano, Silvia; Rubatto, Marco; Fava, Paolo; Ribero, Simone; Quaglino, Pietro | |
| Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks | 2022 | Mastorino, L; Cantafio Duò, V L; Vecco, C; Gelato, F; Giordano, S; Roccuzzo, G; Cavaliere, G; Avallone, G; Ortoncelli, M; Ribero, S; Quaglino, P | |
| Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas | 2022 | Berrino, Enrico; Annaratone, Laura; Bellomo, Sara Erika; Ferrero, Giulio; Gagliardi, Amedeo; Bragoni, Alberto; Grassini, Dora; Guarrera, Simonetta; Parlato, Caterina; Casorzo, Laura; Panero, Mara; Sarotto, Ivana; Giordano, Silvia; Cereda, Matteo; Montemurro, Filippo; Ponzone, Riccardo; Crosetto, Nicola; Naccarati, Alessio; Sapino, Anna; Marchiò, Caterina | |
| New and emerging therapies in cutaneous T-cell lymphoma | 2024 | Roccuzzo, Gabriele; Macagno, Nicole; Giordano, Silvia; Fava, Paolo; Quaglino, Pietro | |
| Nonmelanoma skin cancer arising on tattoos | 2022 | Rubatto, Marco; Gelato, Federica; Mastorino, Luca; Giordano, Silvia; Ribero, Simone; Quaglino, Pietro | |
| Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center | 2023 | Roccuzzo, Gabriele; Giordano, Silvia; Granato, Thomas; Cavallo, Francesco; Mastorino, Luca; Avallone, Gianluca; Pasini, Barbara; Quaglino, Pietro; Ribero, Simone | |
| Pyoderma gangrenosum during infliximab in severe hidradenitis suppurativa: A paradoxical event | 2024 | Giordano, Silvia; Repetto, Federica; Boskovic, Sara; Roccuzzo, Gabriele; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone; Quaglino, Pietro | |
| Pyogenic-granuloma-like skin metastasis as first sign of hepatocarcinoma | 2024 | GIORDANO, Silvia; ROCCUZZO, Gabriele; WITEL, Gianluca; CHIUSA, Luigi; CASSONI, Paola; RIBERO, Simone; QUAGLINO, Pietro | |
| Rapidly evolving nasal ulceration: a clinical challenge | 2023 | ROCCUZZO, Gabriele; BARDINI, Daniela; GIORDANO, Silvia; CONTI, Luca; RIBERO, Simone; QUAGLINO, Pietro | |
| Reply to ‘The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et al | 2022 | Avallone G.; Giordano S.; Astrua C.; Merli M.; Senetta R.; Conforti C.; Ribero S.; Marzano A.V.; Quaglino P. |